Oct 15, 2024, 11:55
Overall survival with Pembrolizumab in early-stage TNBC – Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X:
“Check out this Practice Update commentary from Dr. Stefania Morganti and Dr. Sara Tolaney on overall survival with Pembrolizumab in early-stage TNBC.
Overall Survival With Pembrolizumab in Patients With Early-Stage TNBC
Authors: Stefania Morganti, Sara M. Tolaney.”
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 3, 2024, 17:46
Nov 3, 2024, 16:51
Nov 3, 2024, 16:48
Nov 3, 2024, 16:45
Nov 3, 2024, 16:34